Central nervous system pathology in patients with the Guillain-Barre syndrome

Brain

Volumn 120, Issue 3, 1997, Pages 451-464

  Maier, Hans ^a,c   Schmidbauer, Manfred ^a,b,d   Pfausler, Bettina ^c   Schmutzhard, Erich ^c   Budka, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d Department of Neurology   (Austria)

Author keywords

Cell infiltrates; Central nervous system; Guillain Barre syndrome; Lymphocyte subsets; Neuropathology

Indexed keywords

ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; NERVE CELL; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPINAL CORD; SURVIVAL TIME;

EID: 0030905473     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.3.451     Document Type: Article

References (40)

1. Al-Din AN, Anderson M, Bickerstaff ER, Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher. Brain 1982; 105: 481-95.
2. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 1969; 48: 173-215.
3. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978; 3: 565-6.
4. Barontini F, Sitá D. The nosological position of Fisher's syndrome (ophthalmoplegia, ataxia and areflexia). J Neurol 1983; 229: 33-44.
5. Best PV. Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathol (Berl) 1985; 67: 230-4.
6. Brechenmacher C, Vital C, Deminiere C, Laurentjoye L, Castaing Y, Gbikpi-Benissan G, et al. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 1987; 6: 19-24.
7. Carpenter S. An ultrastructural study of an acute fatal case of Guillain-Barré syndrome. J Neurol Sci 1972; 15: 125-40.
8. Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21: 32-40.
9. Dehaene I, Martin JJ, Geens K, Cras P. Guillain-Barré syndrome with ophthalmoplegia: clinicopathologic study of the central and peripheral nervous systems, including the oculomotor nerves. Neurology 1986; 36: 851-4.
10. de la Monte SM, Ropper AH, Dickersin GR, Harris NL, Ferry JA, Richardson EP Jr. Relapsing central and peripheral demyelinating diseases. Unusual pathologic features. Arch Neurol 1986; 43: 626-9.
11. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986; 109: 1115-26.
12. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993; 116: 185-92.
13. Gehrmann J, Kreutzberg GW. Monoclonal antibodies against macrophages/microglia: immunocytochemical studies of early microglial activation in experimental neuropathology. Clin Neuropathol 1993; 12: 301-6.
14. Gehrmann J, Gold R, Linington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW. Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation. Lab Invest 1992; 67: 100-13.
15. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves. A review. [Review]. J Neuropathol Exp Neurol 1993; 52: 553-60.
16. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome: a clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949; 28: 59-141.
17. Honavar M, Tharakan JK, Hughes RAC, Leibowitz S, Winer JB. A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. Brain 1991; 114: 1245-69.
18. Hughes RAC. Guillain-Barré syndrome. London: Springer-Verlag, 1990.
19. Izumo S, Linington C, Wekerle H, Meyermann R. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats. Lab Invest 1985; 53: 209-18.
20. Julien J, Vital C, Lagueny A, Ferrer X, Brechenmacher C. Chronic relapsing idiopathic polyneuropathy with primary axonal lesions. J Neurol Neurosurg Psychiatry 1989; 52: 871-5.
21. Kanda T, Hayashi H, Tanabe H, Tsubaki T, Oda M. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 1989; 52: 857-64.
22. Lassmann H, Budka H, Schnaberth G. Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol 1981; 38: 99-102.
23. Lassmann H, Fierz W, Neuchrist C, Meyermann R. Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 1991; 114: 429-42.
24. Ormerod IEC, Waddy HM, Kermode AG, Murray NMF, Thomas PK. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 1990; 53: 789-93.
25. Phillips MS, Stewart S, Anderson JR. Neuropathological findings in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1984; 47: 492-5.
26. Poppema S, Lai R, Visser L. Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL-1 by the absence of monocyte reactivity. Am J Pathol 1991; 139: 725-9.
27. Poser CM. The peripheral nervous system in multiple sclerosis. A review and pathogenetic hypothesis. [Review]. J Neurol Sci 1987; 79: 83-90.
28. Prineas JW. Acute idiopathic polyneuritis. An electron microscope study. Lab Invest 1972; 26: 133-47.
29. Radzun HJ, Hansmann M-L, Heidebrecht HJ, Bödewadt-Radzun S, Wacker HH, Kreipe H, et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest 1991; 65: 306-15.
30. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. [Review]. J Neuropathol Exp Neurol 1994; 53: 328-37.
31. Ropper AH. The CNS in Guillain-Barré syndrome [editorial]. Arch Neurol 1983; 40: 397-8.
32. Rubin M, Karpati G, Carpenter S. Combined central and peripheral myelinopathy. Neurology 1987; 37: 1287-90.
33. Schmidbauer M, Budka H, Ambros P. Herpes simplex virus (HSV) DNA in microglial nodular brainstem encephalitis. J Neuropathol Exp Neurol 1989a; 48: 645-52.
34. Schmidbauer M, Budka H, Ulrich W, Ambros P. Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization [published erratum appears in Acta Neuropathol (Berl) 1990; 79: 579]. Acta Neuropathol (Berl) 1989b; 79: 286-93.
35. Schmidbauer M, Budka H, Pilz P, Kurata T, Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992; 115: 383-98.
36. Tachi N, Ishikawa Y, Tsuzuki A, Minami R, Sasaki K, Shinoda M. A case of childhood multiple sclerosis with peripheral neuropathy. Neuropediatrics 1985; 16: 231-4.
37. Thomas PK. The Guillain-Barré syndrome: no longer a simple concept [editorial]. J Neurol 1992; 239: 361-2.
38. Thomas PK, Walker RWH, Rudge P, Morgan-Hughes JA, King RHM, Jacobs JM, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987; 110: 53-76.
39. Yoshino T, Mukuzono H, Aoki H, Takahashi K, Takeuchi T, Kubonishi I, et al. A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues. Am J Pathol 1989; 134: 1339-46.
40. Van Zandycke M, Martin JJ, Vande Gaer L, Van den Heyning PJ. Facial myokymia in the Guillain-Barré syndrome: a clinicopathologic study. Neurology 1982; 32: 744-8.